Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antioxidants on Skin Blood Flow During Local Heating
NCT03680638Phase 1Completed
- Sponsor
- The University of Texas at Arlington
- Start
- Sep 2016
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of tempol, apocynin and allopurinol in obesity and cardiovascular disease (CVD) (4 arms), sponsored by The University of Texas at Arlington. Primary endpoint: Vasodilator Responses to Local Heating with Antioxidant Supplementation. Started Sep 2016; status: completed.
02
Drugs
tempolapocyninallopurinol
03
Conditions
obesitycardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT03680638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03680638.